Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06111027
PHASE1/PHASE2

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

Sponsor: University of Minnesota

View on ClinicalTrials.gov

Summary

The general aim of the study was to provide evidence for the usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (laryngeal dystonia). This work addresses a clinical need to develop alternative or auxiliary treatments for a rare voice disorder with limited treatment options.

Official title: Usability of Laryngeal Vibro-tactile Stimulation as a Non-invasive Treatment for the Voice Disorder Spasmodic Dysphonia

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2023-11-21

Completion Date

2024-10-31

Last Updated

2026-06-25

Healthy Volunteers

No

Interventions

DEVICE

Vibro-tactile stimulation

Participants received vibro-tactile stimulation (VTS) as a non-invasive treatment option. Stimulators were a pair of light-weight encapsulated cylindrical vibrators applied to both sides of the larynx (voice box). The vibration frequency for VTS was set be to 100Hz. During VTS, participants feel a mild tingling or vibrating sensation at their larynx. They applied VTS at home over a period of 8 weeks with a daily dosage of 20 minutes. During weeks 1-4, the weekly dosage of VTS was gradually increased (week 1: 3 days/wk; week 2: 4 days/wk; week 3: 5 days/wk; week 4: 6 days/wk). During weeks 5-8, participants applied VTS on self-selected days as needed, not exceeding 6 times a week.

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States